Search Tag: Venous Thromboembolism



2022 02 Aug

Septic patients are often affected by coagulation disorders. Hence, they are at a high risk of thrombotic complications, ranging from widespread microvascular involvement, such as disseminated intravascular coagulation, to venous thromboembolism, arising as deep vein thrombosis or pulmonary embolism. Over the years, knowledge about the interconnected...Read more

ICU Management


2018 13 Jun

There is concern about excessive bleeding when low-molecular-weight heparins (LMWHs) are used for venous thromboembolism (VTE) prophylaxis in renal dysfunction. To evaluate whether LMWH VTE prophylaxis was safe and effective in critically ill patients with renal dysfunction, researchers conducted a subgroup analysis of PROTECT, a randomised trial...Read more

ICU Management


2016 02 Jun

The first European recommendations on postoperative venous thromboembolism (VTE)  are on their way, and are intended to be much more practical and clinical than the U.S. recommendations, said Prof. Charles-Marc Samama , Chair of the European Task Force on Prevention of  Venous Thromboembolism in Anaesthesia and Intensive Care and Chair of the ESA...Read more

Executive Health Management


2015 22 Dec

One-on-one feedback and written report cards are effective tools for helping surgery residents do better in preventing dangerous blood clots among hospitalised patients, according to a new Johns Hopkins study published in Annals of Surgery . Researchers explain that the feedback strategy was designed to enhance the use of correct therapy in surgery...Read more

ICU Management


2014 17 Nov

Key Messages 1. We need to Identify high risk patients early on during their hospital admission. 2. Recognise anticoagulant prophylaxis may not be suitable for all patients therefore consider other interventions to protect against VTE. 3. Focus on sustained education of healthcare professionals to increase   Venous thromboembolism...Read more

ICU Management


2014 01 Nov

According to a study published in JAMA, prevention of venous thromboembolism (VTE) with low-molecular-weight heparin (LMWH) dalteparin in critically ill patients was more effective and had similar or lower costs  compared to unfractionated heparin (UFH). The study is to be presented at the Critical Care Canada Forum. The PROTECT trial compared the...Read more

Cardiology Management


2014 16 Sep

According to a study published in JAMA, there is no significant difference in the clinical and safety outcomes associated with most treatment strategies for venous thromboembolism, a common medical condition manifested as deep vein thrombosis or pulmonary embolism. Venous thromboembolism is the third leading cause of cardiovascular death....Read more

Executive Health Management


2014 18 Aug

The rate of Venous Thromboembolism Events (VTE) is a key measure used by the Centres for Medicare and Medicaid Services to assess a hospital's quality performance. A recent study, however, suggests that VTE may not reflect quality at all. Instead, it directly reflects how frequently a hospital conducts imaging tests to diagnose the condition. The more tests,...Read more